Logo

American Heart Association

  21
  0


Final ID: MP840

AI-driven Aortic Valve Calcification Measurement in Coronary Artery Calcium Scan Detects Aortic Stenosis Comparably to Human Experts: An AI-CVD Study within the Framingham Heart Study

Abstract Body (Do not enter title and authors here): Background: Aortic valve calcification (AVC) is an early marker of aortic stenosis but is not routinely scored and reported in coronary artery calium (CAC) scans. Traditional manual quantification methods are time-consuming and subject to inter-reader variability, limiting their scalability in clinical practice. The AI-CVD initiative (see figure 1) aims to extract all useful opportunistic screening information from CAC scans to maximize prediction of cardiovascular diseases (CVD).
Hypothesis: We hypothesized that the AI-CVD measurements of AVC in CAC scans performs comparably to manual measurements by human experts.
Methods: We analyzed 742 CAC scans from the Framingham Heart Study Offspring cohort, acquired between 2002 and 2005 who also had an echocardiogram with aortic valve analysis. The AI model was trained to segment each aortic valve leaflet and quantify calcification using the Agatston criteria (>130HU and ≥1mm2). Manual AVC scores were previously computed by trained huamn experts. The primary outcome was clinically diagnosed aortic stenosis, identified cross-sectionally from health records. We compared the performance of AI-CVD and manual AVC scores using the area under the receiver operating characteristic (AUC) analysis and confusion matrix metrics, including sensitivity, specificity, positive predictive value, negative predictive value, and F1 score.
Results: Among 742 participants, 22 had a clinical diagnosis of aortic stenosis. 18 cases of aortic stenosis were correctly identified by AI-measured AVC compared to 15 cases by manual measurements. The AUC for aortic stenosis diagnosis for AI-CVD AVC was 0.934 vs. 0.883 for huamn experts. Confusion matrices and ROC curves support the improved accuracy and lower false negative rate of AI-based measurement versus human experts.
Conclusion: AI-CVD AVC score detects aortic stenosis comparably to manual measurements by huamn experts in the Framingham Heart Study Offspring Cohort. These findings support the integration of AI-enabled opportunistic screening into CAC scans to maximize CVD prediction beyond the CAC score.
  • Naghavi, Morteza  ( HeartLung Technologies , Palo Alto , California , United States )
  • Atlas, Kyle  ( HeartLung Technologies , Palo Alto , California , United States )
  • Zhang, Chenyu  ( HeartLung Technologies , Palo Alto , California , United States )
  • Reeves, Anthony  ( Cornell University , Ithaca , New York , United States )
  • Atlas, Thomas  ( Tustin Teleradiology , Tustin , California , United States )
  • Wasserthal, Jakob  ( University Basel , Basel , Switzerland )
  • Yankelevitz, David  ( Mount Sinai Hospital , New York , New York , United States )
  • Henschke, Claudia  ( Mount Sinai Hospital , New York , New York , United States )
  • Wong, Nathan  ( University of California, Irvine , Irvine , California , United States )
  • Author Disclosures:
    Morteza Naghavi: DO have relevant financial relationships ; Ownership Interest:HeartLung.AI:Active (exists now) | Kyle Atlas: No Answer | Chenyu Zhang: DO have relevant financial relationships ; Employee:HeartLung Corporation:Active (exists now) ; Individual Stocks/Stock Options:HeartLung Corporation:Active (exists now) | Anthony Reeves: DO have relevant financial relationships ; Individual Stocks/Stock Options:HeartLung Technologies:Active (exists now) | Thomas Atlas: No Answer | Jakob Wasserthal: DO have relevant financial relationships ; Consultant:HeartLungAi:Active (exists now) | David Yankelevitz: DO have relevant financial relationships ; Royalties/Patent Beneficiary:General Electric:Active (exists now) ; Individual Stocks/Stock Options:Accumetra:Active (exists now) ; Advisor:Lunglife AI:Active (exists now) ; Advisor:Carestream:Active (exists now) ; Advisor:Median Technology:Active (exists now) ; Individual Stocks/Stock Options:HeartLung:Active (exists now) | Claudia Henschke: No Answer | Nathan Wong: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen, Novartis, Ionis:Active (exists now) ; Consultant:Ionis:Past (completed) ; Speaker:Novartis:Past (completed) ; Consultant:Heart Lung, Amgen, Novartis:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk, Regeneron:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Aortic Stenosis Reimagined: Innovations in Diagnosis, Prognostication, and Treatment Paradigms

Saturday, 11/08/2025 , 09:15AM - 10:15AM

Moderated Digital Poster Session

More abstracts on this topic:
Activin Signaling Inhibition Enhances Cardiac Functional Recovery After Aortic Debanding

Singh Anand, Guseh James Sawalla, Xiao Chunyang, Babbs Keith, Seehra Jasbir, Li Haobo, Rosenzweig Anthony

A Deep Learning Digital Biomarker for Mitral Valve Prolapse using Echocardiogram Videos

Al-alusi Mostafa, Khurshid Shaan, Sanborn Danita, Picard Michael, Ho Jennifer, Maddah Mahnaz, Ellinor Patrick, Lau Emily, Small Aeron, Reeder Christopher, Shnitzer Dery Tal, Andrews Carl, Kany Shinwan, Ramo Joel, Haimovich Julian

More abstracts from these authors:
AI-enabled Ascending Aorta and Pulmonary Trunk Volumetry in Coronary Artery Calcium Scans for Heart Failure Prediction: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Wong Nathan, Wasserthal Jakob, Henschke Claudia, Yankelevitz David

Identification of High Risk Cases in Coronary Artery Calcium (CAC) Scans based on CAC Score and AI-driven Cardiometabolic Biomarkers: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Naghavi Morteza, Wong Nathan, Kloner Robert, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Branch Andrea, Wasserthal Jakob, Atlas Thomas, Yankelevitz David, Henschke Claudia

You have to be authorized to contact abstract author. Please, Login
Not Available